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Abstract 
Background: Carcinoma associated fibroblasts (CAFs), an important component of tumor microenvironment, are 
capable of enhancing tumor cells invasion and migration through initiation of epithelial–mesenchymal transition 
(EMT). MRC-5 fibroblasts are one of the CAFs expressing alpha-smooth muscle actin. It is ascertained that medium 
conditioned by MRC-5 fibroblasts stimulate motility and invasion of breast cancer cells. However, its role in hepatocel-
lular carcinoma (HCC) is less clear. The aim of our study was to investigate the effect of MRC-5-CM on HCC and explore 
the underlying mechanisms.
Methods and results: Using a combination of techniques, the role of MRC-5-CM in HCC was evaluated. We deter-
mined that MRC-5-CM induced the non-classical EMT in Bel-7402 and MHCC-LM3 cell lines. Initiation of the non-clas-
sical EMT was mainly via quintessential redistribution of α-, β- and γ-catenin, P120 catenin, E-cadherin, and N-cad-
herin, rather than up-regulation of typical EMT-related transcription factors (i.e., Snail, Twist1, ZEB-1 and ZEB2). We also 
found that MRC-5-CM potentiated both the migration and invasion of Bel-7402 and MHCC-LM3 cells in mesenchymal 
movement mode through activation of the α6, β3, β4, β7 integrin/FAK pathway and upregulation of MMP2. The flow 
cytometric analysis showed that MRC-5-CM induced G1 phase arrest in Bel-7402 cells with a concomitant reduction 
of S phase cells. In contrast, MRC-5-CM induced S phase arrest in MHCC-LM3 cells with a concomitant reduction of 
cells in the G2/M phase. MRC-5-CM also inhibited apoptosis in Bel-7402 cells while inducing apoptosis in MHCC-LM3 
cells.
Conclusion: Collectively, MRC-5-CM promoted HCC cell motility and invasiveness through initiation of the non-
classical EMT, including redistribution of α-, β- and γ-catenin, P120 catenin, E-cadherin, and N-cadherin, activation of 
the integrin/FAK pathway, and upregulation of MMP2. Hence, MRC-5-CM exerted distinct roles in Bel-7402 and MHCC-
LM3 cell viability by regulating cyclins, cyclin dependent kinases (CDKs), CDK inhibitors (CKIs), Bcl-2 family proteins 
and other unknown mechanosensors.
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Background
Hepatocellular carcinoma (HCC) ranks as the fifth most 
common cancer in men (554,000 cases, 7.5% of the total) 
and the ninth in women (228,000 cases, 3.4%) [1]. Despite 
advancements in early diagnosis and surgical treatment 
over the last few decades, HCC remains the third most 
common cause of cancer-related death worldwide [2, 3]. 
The aggressive nature of HCC is, by and large, attributed 
to vascular invasion and resistance to apoptosis [4, 5]. 
Hence, the current pressing matter is identification of the 
crucial pathways linked to HCC invasion/metastasis and 
apoptosis/proliferation.
The epithelial–mesenchymal transition (EMT) has 
been suggested to be involved in the progression of vari-
ous cancers, including HCC [6]. Tumor cells that have 
undergone the EMT exhibit increased invasive/meta-
static and apoptosis-resistant properties, among oth-
ers. Several pathways capable of inducing the EMT 
have been identified [6–8] and the roles of transcription 
factors (i.e., Snail, Twist1, ZEB-1 and ZEB-2) in EMT 
modulation have also been evaluated [9–12]. However, 
the exact mechanism of the EMT remains incompletely 
understood and currently appears as the tip of the ice-
berg. Recent reports have highlighted that integrins and 
laminins as the main components of the cell adhesion 
functional unit [13], and these molecules are often cor-
related with cancer progression by potentiating the EMT 
via cooperation with other signaling effectors [14, 15]. 
Therefore, there is a compelling need to distinguish the 
specific roles of laminins and integrins in HCC.
The influence of conditioned medium from MRC-5 
fibroblast on breast cancer cell motility and invasion 
potential has been well addressed [16]. However, the 
exact mechanisms remain elusive. In this study, the effect 
of MRC-5 fibroblast-conditioned medium (MRC-5-CM) 
on HCC cell proliferation, apoptosis, cell motility and 
invasion was examined. Further, we evaluated the expres-
sion profiles of cell cycle- and apoptosis-associated pro-
teins, EMT-related proteins, matrix metalloproteases 
(MMPs), laminins, integrins, and other adhesion mol-
ecules to explore there associated molecular mechanisms 
in HCC cells. These findings will be useful for the identi-




The human lung fibroblast cell line MRC-5 was a gener-
ous gift from Dr. Xi Chen (Zhejiang University, China). 
Bel-7402 and MHCC-LM3 cell lines were purchased 
from Shanghai Cell Bank, Chinese Academy of Sciences. 
MRC-5 cells were maintained in RPMI-1640 media 
(Gibco) supplemented with 10% fetal bovine serum (FBS; 
Sigma-Aldrich) at 37°C in a 5% CO2 water-saturated 
environment. Conditioned medium of MRC-5 cells was 
collected as follows. Cells were cultured until 70–90% 
confluency, at which point the used medium was col-
lected and passed through a 0.22-µm filter, diluted at a 
1:1 ratio with RPMI-1640 containing 10% FBS. RPMI-
1640 medium supplemented with 10% FBS serverd as 
the control medium. Bel-7402 and MHCC-LM3 cells 
were respectively cultured in the conditioned medium 
from MRC-5 cells for 21 days (n = 3). Bel-7402 was sub-
cultured once a week at a ratio of 1:3 or 1:5. MRC-5 and 
MHCC-LM3 were subcultured once a week at a ratio of 
1:1 or 1:2. 5  ml MRC-5-CM was used when HCC cells 
were cultured in 25 cm2 cell culture flasks. 20 ml MRC-
5-CM was used when HCC cells were cultured in 75 cm2 
cell culture flasks.
Transwell assay
The migration and invasion assays were performed using 
Transwell chambers with 8  µm pore filters (Millipore, 
Billerica, MA, USA). The filters used for invasion assays 
were coated with 30  µl pre-diluted Matrigel (diluted at 
a ratio of 1:8 with serum-free RPMI-1640 medium) (BD 
Bioscience, San Jose, CA, USA). 5 ×  104  cells in 0.3  ml 
serum-free RPMI-1640 medium were added to the upper 
chambers. Then, 0.8  ml RPMI-1640 medium supple-
mented with 10% FBS was added to the lower chambers 
as a chemoattractant. After incubation for 48 h, cells on 
the upper membrane surface were wiped off, and the cells 
that invaded across the Matrigel membrane were washed 
with phosphate-buffered saline (PBS), fixed with 100% 
methanol, rinsed in PBS, and stained with 0.2% crystal 
violet. The invaded cells were counted (5 randomly cho-
sen high-power fields for each membrane) under a light 
microscope (at 200× magnification). The filters used 
for migration assays were not coated with Matrigel. All 
experiments were performed at least in triplicate.
Western‑blot analysis
Whole cells were lysed on ice in a lysis buffer (RIPA, Beyo-
time, Shanghai, China) with a protease inhibitor mixture 
cocktail (Roche, Switzerland) after culturing in MRC-
5-CM for 21 days. After centrifugation at 12,000 rpm for 
30  min at 4°C, the protein concentrations of superna-
tants in samples were measured by the BCA protein assay 
(Thermo scientific, Rockford, IL, USA). Equal amounts 
of protein (50  µg) were separated by 10–12% NUPAGE 
Bis–Tris Gel (Invitrogen, CA, USA) electrophoresis 
(constant voltage: 120  mv) and transferred onto polyvi-
nylidene fluoride (PVDF, 0.45  µm) membranes (constant 
current: 350 mA for 70/120 min). After being blocked by 
Tris-buffered saline and Tween 20 (TBST) buffer con-
taining 5% non-fat powder milk for 2  h, the membranes 
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were incubated with primary antibodies overnight on 
ice. After washing the membranes several times in TBST 
while agitating, detection was performed using the appro-
priate secondary HRP-conjugated anti-mouse or anti-
rabbit antibody. Immunoreactive bands on the blots were 
visualized with enhanced chemiluminescence reagent 
ECL kit (Beit Haemek, Israel) and intensities were quan-
tified using Glyko BandScan 5.1 software. Anti-α, β and 
γ-catenin, anti-E-cadherin, anti-ZO-1, anti-N-cadherin, 
anti-Fibronectin, anti-ZEB-1, ZEB-2, Snail, and Twsit1 and 
anti-vimentin primary antibodies were purchased from 
(Abcam); anti-MMP-1, 2, 3, 11, 12, 13, 14, 17 and 21, anti-
p53, anti Annexin IV, anti-Vitronectin, anti-Ezrin, anti-
P120, anti-Laminin A1, Laminin B3, anti-Integrin A6, B1, 
B3, B4 and B7, anti-FAK, P-FAK-Y397, Src and P-Src-Y529 
primary antibodies were purchased from (Epitomics); anti-
Cdc-2, P-Cdc-2-Tyr15, CDK4, CDK6, Cyclin A, Cyclin D1, 
Cyclin D3, Cyclin E2, P15, P16, P21,P27, Rb, P-Rb-S811, 
P-Rb-S795, P-Rb-S780; anti-Bcl-2, P-Bcl-2-Thr56, Bcl-xl, 
Bad, P-Bad-Ser112, Bak, Bax, Bik, Mcl-1, Puma and anti-β-
actin were from (Cell Signaling Technology).
Confocal immunofluorescent analysis
5 × 105 cells were implanted onto a cell culture dish for 
24 h (NEST Biotech, Hong Kong, China) after culturing 
in MRC-5-CM for 21  days. Confocal immunofluores-
cent analysis: cells were fixed with paraformaldehyde for 
30  min, then permeabilized with 0.1% Triton X-100 for 
10 min at room temperature, and thereafter sealed with 
goat serum for 1  h at room temperature following pri-
mary antibodies incubation in the dark for 24  h at 4°C. 
Washed three times with PBS and then cells were incu-
bated with Alexa Flour® 488 IgG donkey anti-mouse or 
anti-rabbit second antibodies (1:300, Invitrogen, USA) in 
the dark for 1 h at room temperature. Then, nuclei were 
stained with propidium iodide for 5  min. Fluorescence 
images were photographed with confocal microscopy 
(Leica DMIRE2, Germany) (at 10 × 63 magnification).
Flow cytometry
For cell cycle analysis, the cells were fixed with ice-cold 
75% ethylalcohol at 4°C overnight and incubated with 
propidium iodide (BD Bioscience, CA) at 4°C in the dark 
for 30  min. For apoptosis analysis, cells were incubated 
with Annexin V-FITC (BD Bioscience, CA) and propid-
ium iodide for 15 min at 4°C in the dark. After staining, 
the cells were analyzed using a flow cytometer (CYTOM-
ICS FC 500, Beckman Coulter, Miami, FL, USA). All 
experiments were performed at least in triplicate.
Statistical analysis
Independent Student t test was used to analyze the differ-
ences between 2 groups using SPSS 16.0 software (SPSS, 
Chicago, IL, USA). Statistical significance was accepted if 
p < 0.05.
Results
Cell morphology and cell motility
Bel-7402 cells were cultured in MRC-5-CM, hereaf-
ter referred to as Bel-7402-(MRC-5)-CM. MHCC-LM3 
cells were cultured in MRC-5-CM, hereafter referred to 
as MHCC-LM3-(MRC-5)-CM. After culturing in MRC-
5-CM for 21  days, Bel-7402-(MRC-5)-CM cells became 
elongated and spread-out. The cell motility and inva-
siveness potentials were significantly augmented com-
pared with control (the results have been previously 
published). Similarly, after culturing in MRC-5-CM for 
21 days, MHCC-LM3-(MRC-5)-CM cells were extended 
and broad elaborate cell protrusions were observed. The 
cell motility and invasiveness potentials were also signifi-
cantly enhanced (P < 0.05, Figure 1).
Expression of EMT‑related proteins, laminins and integrins
The EMT has been implicated in human cancer metas-
tasis. To determine the mechanism of enhanced invasion 
and migration of Bel-7402-(MRC-5)-CM and MHCC-
LM3-(MRC-5)-CM, the expression profiles of epithelial 
markers E-cadherin, α-catenin and ZO-1; mesenchymal 
markers N-cadherin, β-catenin and Fibronectin; and 
EMT-promoting transcription factors Snail, Twsit1, ZEB-
1, and ZEB-2 and MMP-1, -2, -3, -11, -12, -13, -14, -17, 
-21 were evaluated by Western-blot analysis (Figure 2a). 
Mesenchymal markers Snail, Twist1, ZEB-1, ZEB-2, 
N-cadherin, β-catenin and fibronectin were reduced 
in Bel-7402-(MRC-5)-CM compared with the control 
(Bel-7402). The epithelial marker ZO-1 was increased. 
However, α-catenin remained unchanged. Furthermore, 
E-cadherin was downregulated. The expression pro-
files of MMPs showed that the expressions of MMP-2 
and -3 were markedly upregulated in Bel-7402-(MRC-
5)-CM, whereas MMP-1, -11, -13, -14 and -21 remained 
unchanged. Conversely, MMP-12 and -17 were reduced.
The expression of EMT-related proteins was also evalu-
ated in MHCC-LM3 and in MHCC-LM3-(MRC-5)-CM 
(Figure  2a). Mesenchymal markers Twist1, ZEB-2, and 
N-cadherin were increased in MHCC-LM3-(MRC-5)-CM 
compared with the control (MHCC-LM3). However, 
Snail, ZEB-1 and β-catenin were reduced, while fibronec-
tin remained unchanged. Moreover, epithelial markers 
ZO-1 and E-cadherin were increased. The expression 
profiles of MMPs showed that MMP-2, -14 and MMP-17 
were increased in MHCC-LM3-(MRC-5)-CM. MMP-3, 
-13 and -21 remained unchanged. Conversely, MMP-1, 
-11 and -12 were reduced. Therefore, enhancement of 
invasion and migration of Bel-7402-(MRC-5)-CM and 
MHCC-LM3-(MRC-5)-CM was not via a canonical EMT 
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program. This contradictory phenomenon suggests the 
counterintuitive hypothesis in which MRC-5-CM-stimu-
lated cell migration and invasion in the HCC cells occurs 
via a non-classical EMT pathway.
Laminins and integrins are intimately correlated with 
cancer invasion and metastasis. Therefore, the expres-
sion of laminins, integrins and associated signaling mol-
ecules were evaluated in Bel-7402, Bel-7402-(MRC-5)-CM, 
MHCC-LM3 and in MHCC-LM3-(MRC-5)-CM (Fig-
ure  2b). We concluded that α6 and β3 integrins were 
upregulated in Bel-7402-(MRC-5)-CM and in MHCC-
LM3-(MRC-5)-CM relative to the control. β7 integrin was 
significantly increased in Bel-7402-(MRC-5)-CM and mod-
erately increased in MHCC-LM3-(MRC-5)-CM. β4 integrin 
was increased significantly in MHCC-LM3-(MRC-5)-CM 
and moderately increased in Bel-7402-(MRC-5)-CM. 
Figure 1 Alterations in cell morphology and motility. a Morphological changes in MHCC-LM3 cells after culture in MRC-5-CM. b Transwell assays 
are shown: histograms represent cell invasion and migration over 72 h. Invasion and migration of MHCC-LM3 cells cultured in MRC-5-CM for 21 days 
were increased relative to the control (P < 0.05).
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Laminin A1 was upregulated only in Bel-7402-(MRC-
5)-CM, while laminin B3 was upregulated only in MHCC-
LM3-(MRC-5)-CM. β1 integrin remained unchanged. 
P-FAK-Y397 was significantly up-regulated in both Bel-
7402-(MRC-5)-CM and MHCC-LM3-(MRC-5)-CM. 
Src remained unchanged in Bel-7402-(MRC-5)-CM but 
was silenced in MHCC-LM3-(MRC-5)-CM. P-Src-Y529 
which inactivates Src, was reduced in Bel-7402-(MRC-
5)-CM but increased in MHCC-LM3-(MRC-5)-CM. Col-
lectively, these data indicate that Bel-7402-(MRC-5)-CM 
and MHCC-LM3-(MRC-5)-CM increase in cell motility 
through elevated expression of laminins, integrins, the acti-
vated form of FAK and other downstream signaling mol-
ecules (the ratio discrepancy was listed in Additional files 1, 
2, 3, 4: Figure S1–4).
Redistribution of epithelial and mesenchymal markers 
and cell motility‑associated adhesion molecules
To further explore the mechanisms of enhanced cell 
invasion and migration in Bel-7402-(MRC-5)-CM and 
Figure 2 Protein expression alterations in Bel-7402 and MHCC-LM3 cells cultured in MRC-5-CM for 21 days. a The expression profiles of epithelial 
markers, mesenchymal markers and MMPs. b The expression profiles laminins, integrins, FAK and Src.
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MHCC-LM3-(MRC-5)-CM, immunofluorescence analy-
sis was performed. The expression of α-, β- and γ-catenin 
and P120 catenin on cell membrane were significantly 
reduced in Bel-7402-(MRC-5)-CM relative to the con-
trol, and N-cadherin was distributed in a disorderly 
fashion on Bel-7402-(MRC-5)-CM cell membranes. 
However, reduced membrane expression of E-cad-
herin in Bel-7402-(MRC-5)-CM was not observed, the 
basic membrane expression of E-cadherin in Bel-7402 
is relatively low, which could explain this observation. 
Vimentin and β7 integrin were increased dramatically, 
while Ezrin (which serves as an intermediate between 
the plasma membrane and the actin cytoskeleton) was 
decreased moderately. Vitronectin which promotes cell 
spreading and migration through specific interactions 
with integrins, was upregulated slightly. Annexin IV 
Figure 3 Immunofluorescence analysis of epithelial markers, mesenchymal markers and cell motility-associated adhesion molecules in Bel-7402 
cells compared with Bel-7402-(MRC-5)-CM. Green fluorescence represents staining of the corresponding protein; red fluorescence represents nuclear 
DNA staining by DAPI. Fluorescence images were captured using a confocal microscope (at 10 × 63 magnification).
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(which is implicated in a range of cellular functions such 
membrane aggregation, actin configuration, and signal-
ing) was up-regulated slightly (Figure  3). These results 
also revealed that membrane expression of α-, β- and 
γ-catenin, P120 catenin and E-cadherin were reduced 
in MHCC-LM3-(MRC-5)-CM compared with the con-
trol, and N-cadherin was localized in a disorderly fash-
ion on the MHCC-LM3-(MRC-5)-CM cell membrane. 
The results also showed that γ-catenin in MHCC-LM3-
(MRC-5)-CM had an increasing tendency to translocate 
to the nucleus. Vimentin and β7 integrin were increased 
to varying degrees. Vitronectin, annexin IV and Ezrin 
were decreased to varying degrees (Figure  4). These 
results suggest that Bel-7402-(MRC-5)-CM and MHCC-
LM3-(MRC-5)-CM were induced to undergo non-classi-
cal EMT via redistribution of α-, β-and γ-catenin, P120 
Figure 4 Immunofluorescence analysis of epithelial markers, mesenchymal markers and cell motility-associated adhesion molecules in MHCC-
LM3 cells compared with MHCC-LM3-(MRC-5)-CM. Green fluorescence represents staining of the corresponding protein; red fluorescence represents 
nuclear DNA staining by DAPI. Fluorescence images were captured using a confocal microscope (at 10 × 63 magnification).
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catenin and E-cadherin. Integrins and other adhesion 
molecules could also be implicated in this induction. 
These results also reflect dissimilarities in the effect of 
MRC-5-CM on different cancer cell types. (The fluores-
cence intensity comparison was showed in Additional 
files 5, 6: Figure S5–6).
Effect of MRC‑5‑CM on Bel‑7402 and MHCC‑LM3 cell 
viability
To explore the effect MRC-5-CM on tumor cell growth, 
flow cytometry was used to investigate cell cycle progres-
sion and apoptosis. We found that MRC-5-CM induced 
G1 phase arrest in Bel-7402 cells, while simultaneously 
inducing S phase arrest in MHCC-LM3 cells (Figure 5a). 
We also found that MRC-5-CM inhibited apoptosis in 
Bel-7402 cells while inducing apoptosis in MHCC-LM3 
cells (Figure  5b), further suggesting variations in the 
effect of MRC-5-CM on different cancer cell types.
To better understand the effect of MRC-5-CM on Bel-
7402 and MHCC-LM3 cell viability, we evaluated the 
expression of cell cycle- and apoptosis-related proteins. 
CDK-4, which is essential for the transition from G1 to 
S phase, was reduced in Bel-7402-(MRC-5)-CM com-
pared with Bel-7402 cells. Moreover, P16 and P53, which 
inhibit cells in G1 phase from entering S phase, were 
up-regulated. However, cyclin D1, CDK-6 and phos-
phorylated Rb (P-Rb-S811, P-Rb-S795 and P-Rb-S780), 
which promote G1-S phase progression, were increased. 
Furthermore, P27, which can impede G1-S transition, 
were unexpectedly down-regulated. Meanwhile, cyclins 
A and E2, which accelerate the shift into S phase, were 
downregulated. Cdc-2, which permits the entry of cells 
from G2 phase into M phase, was decreased, but Tyr15-
phosphorylated Cdc-2 (results in Cdc-2 inhibition), was 
increased. P15, P21, Rb and Cyclin D3 was not changed 
significantly in Bel-7402-(MRC-5)-CM (Figure 6a). These 
results also showed that CDK-4 was reduced in MHCC-
LM3-(MRC-5)-CM compared with MHCC-LM3. In 
contrast, Cyclin A, CDK-6 and phosphorylated Rb (P-Rb-
S795 and P-Rb-S780) were up-regulated. Moreover, P21 
and P27, which halt cell cycle progression were reduced. 
Cyclins D1, D3, P15, P53, and Rb and P-Rb-S811 did 
not differ significantly. Cdc-2 was decreased, but Tyr15-
phosphorylated Cdc-2 was increased. We were unable 
to detect the altered expression of Cyclin E2 or P16 in 
MHCC-LM3-(MRC-5)-CM using equal amounts of 
lysates (50 μg protein), indicating that basal expressions 
was minimal (Figure  6a). On the basis of these results, 
MRC-5 induced G1 phase arrest in Bel-7402 cells and S 
phase arrest in MHCC-LM3 cells may not be mediated 
by cyclin, CDK, CKI, P53, and Rb regulation.
The expression profiles of apoptosis-associated genes 
were also evaluated (Figure  6b). The anti-apoptotic 
Bcl-2 gene was increased in Bel-7402-(MRC-5)-CM 
but reduced in MHCC-LM3-(MRC-5)-CM relative to 
the control. However, the anti-apoptotic Mcl-1 gene 
was reduced in Bel-7402-(MRC-5)-CM, but increased 
in MHCC-LM3-(MRC-5)-CM. Thr56-phosphorylated 
Bcl-2 (interferes with the anti-apoptotic activity of Bcl-
2) was reduced in both MHCC-LM3-(MRC-5)-CM and 
in Bel-7402-(MRC-5)-CM. The anti-apoptotic Bcl-xl 
gene remained unchanged. Pro-apoptotic genes Bax and 
Puma were downregulated in Bel-7402-(MRC-5)-CM, 
but upregulated in MHCC-LM3-(MRC-5)-CM. The pro-
apoptotic Bad gene and phosphorylated Bad (inhibits the 
apoptotic activity of Bad) did not change significantly in 
Bel-7402-(MRC-5)-CM, but increased in MHCC-LM3-
(MRC-5)-CM. Anti-apoptotic genes Bak and Bik were 
increased in Bel-7402-(MRC-5)-CM, but reduced in 
MHCC-LM3-(MRC-5)-CM. In view of this, we speculate 
that the effect of MRC-5-CM on cancer cell apoptosis 
is mediated partly through regulation of the Bcl-2 gene 
family, but these genes may not play an essential role.
Discussion
HCC is prone to rapid infiltration and early diffuse metas-
tases [6]. Because of these pathologic features, the major-
ity of HCC patients are not diagnosed until an advanced 
stage [17], thus reducing the chance of curative treat-
ment. Survival improvement in patients with late-stage 
disease requires a better understanding of the regulatory 
mechanisms of HCC invasion and migration. However, 
these exact mechanisms are likely multi-factorial and 
largely unknown [18]. Remarkably, the EMT has been 
broadly recognized as a critical step in HCC progression 
[19]. EMT is a dedifferentiation program by which epi-
thelial cells lose cell-to-cell contact and concomitantly 
gain mesenchymal characteristics, including invasive and 
migratory abilities. Loss or disruption of tight junctions 
and E-cadherin/β-catenin complexes at cell boundaries 
via up-regulation of E-box repressors such as ZEB-1, 
ZEB-2, Snail, and Twist1 is one of the hallmarks of the 
EMT. However, recent studies have revealed that such 
classical EMT events may be the exception [20]. Many 
normal epithelia migrate efficiently while maintaining 
integrity, although apico-basal polarity is reduced and 
tight junctions decreased. Furthermore, branching mor-
phogenesis of the Drosophila tracheal system was associ-
ated with the migration of epithelial tubes with enriched 
E-cadherin and ZO-1 [21]. Interestingly, these results do 
not prove that EMT is not involved in said movements. 
In fact, the various modes of cell movement are complex 
and include the amoeboid (blebbly), amoeboid (pseu-
dopodal, filopodia), mesenchymal, multicellular stream-
ing, and collective migration modes, some of which are 
interconvertible [22]. The mesenchymal migration mode 
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Figure 5 Analysis of cell cycle progression and apoptosis. a Cell cycle profiles of Bel-7402 and MHCC-LM3 cells after culture in MRC-5-CM for 
21 days were evaluated by flow cytometry. b Apoptotic rate of Bel-7402 and MHCC-LM3 cells after culture in MRC-5-CM for 21 days.
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is characterized by cell–matrix adhesions that become 
focalized. In addition, the cell forms an elongated spin-
dle-shaped morphology with increased cytoskeletal con-
tractility [23]. Integrins mediate the force generation for 
the mesenchymal migration.
Our study demonstrated that Bel-7402-(MRC-5)-CM 
and MHCC-LM3-(MRC-5)-CM displayed mesenchymal 
characteristics, including an elongated, spread-out mor-
phology, the presence of highly dynamic cellular protru-
sions and enhanced migration and invasion potentials. 
Figure 6 Expression profiles of cell cycle and apoptosis-associated proteins. a The expression profiles of cell cycle-associated proteins. b The 
expression profiles of apoptosis-associated proteins
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We hypothesized that Bel-7402-(MRC-5)-CM and 
MHCC-LM3-(MRC-5)-CM were induced to undergo 
non-classical EMT. As the results reveal, the mesenchy-
mal marker vimentin was increased in both cell types. 
In contrast, the E-cadherin/β-catenin complex, as well 
as α-, and γ-catenin and P120 catenin were all decreased 
at the cell surface. Membrane expression of N-cadherin 
(which mediates cell–cell adhesion in stromal cells) was 
increased and localized in a disorderly manner on the 
cell membrane. Classical EMT-promoting transcription 
factors Snail, Twist1, ZEB-1 and ZEB-2 lost their corre-
sponding roles. Epithelial markers ZO-1 and E-cadherin 
were also increased. Interestingly, we found a novel phe-
nomenon in which γ-catenin was more inclined to be 
expressed in the nucleus. It is worth noting that induc-
tion of the non-classical EMT may be mainly via redistri-
bution of α-, β-, and γ-catenin, P120 catenin, E-cadherin 
and N-cadherin.
Laminins, the prominent components of basement 
membranes, are large heterotrimeric glycoproteins com-
posed of one α, one β, and one γ chain. Integrins, a fam-
ily of cell surface adhesion receptors, recognize different 
extracellular matrix components and are comprised of 
one α and one β subunit. Laminins and integrins are inti-
mately related to cancer progression via interaction with 
MMPs. Previous studies revealed that laminins A1 and B3 
can promote the malignant phenotype of melanoma and 
non-small cell lung cancer [24, 25], and α6, β1, β3, β4 and 
β7 integrins were essential for cancerous invasion [26–
30]. The interaction between MMPs and laminins/integ-
rins has received ample attention, and MMP-2 is believed 
to be one of the major proteases involved in mesenchymal 
migration [31–33]. Therefore, we evaluated the expression 
of Laminin A1, Laminin B3,as well as α6, β1, β3, β4 and β7 
integrins, FAK, P-FAK-Y397, Src, P-Src-Y529 and MMPs 
in both Bel-7402-(MRC-5)-CM and MHCC-LM3-(MRC-
5)-CM. In agreement with previous studies, α6, β3, β4 and 
β7 integrins were up-regulated in both cell types. Laminin 
A1 was upregulated in Bel-7402-(MRC-5)-CM while 
Laminin B3 was up-regulated in MHCC-LM3-(MRC-
5)-CM. Moreover, FAK was activated in both cell types in 
response to increased integrin expression. Nevertheless, 
β1 integrin remained unchanged. The expression profiles 
of MMPs indicated that MMP-2 and -3 were up-regulated 
in Bel-7402-(MRC-5)-CM, and that MMP-14, -17 and 
MMP-2 were increased in MHCC-LM3-(MRC-5)-CM. 
On the basis of these results, we speculated that Bel-
7402-(MRC-5)-CM and MHCC-LM3-(MRC-5)-CM were 
promoted to invade and migrate, possibly through activa-
tion of FAK and upregulation of MMP-2. Other adhesion 
molecules, including Vitronectin, Annexin IV, and Ezrin, 
may also be implicated in this mechanism through their 
interactions with laminins/integrins.
Our previous study verified that MRC-5-CM inhib-
ited the mRNA level of β4 integrin in Bel-7402 cells. We 
speculate that MRC-5-CM enables β4 integrin to avoid 
the natural degradation at the post transcriptional level 
by translocation. Thus, β4 integrin could activate down-
stream signal molecules consistently. We also have men-
tioned that β4 integrin is negatively correlated with CK19 
expression (which is a valuable predictor of HCC recur-
rence). It reflects that HCC cells acquire a large amount 
of β4 integrin just at the stage of the metastatic process. 
Therefore, the role of β4 integrin in HCC remains to be 
further explored.
In the present study, we demonstrated that MRC-
CM mediates both cell cycle progression and apop-
tosis. We found that MRC-5-CM induced G1 phase 
arrest in Bel-7402 and S phase arrest in MHCC-LM3 
cells. We also found that MRC-5-CM inhibited apopto-
sis in Bel-7402 while MRC-5-CM induced apoptosis in 
MHCC-LM3 cells. The cell cycle is regulated mainly by 
cyclins, CDKs and CKIs [34–36] whereas apoptosis is 
regulated mainly by the Bcl-2 family of genes [37–39]. 
We examined the expression profiles of cyclins, CDKs, 
CKIs, P53, Rb, phosphorylated Rb, pro-apoptotic Bcl-2 
family proteins (Bad, Bax, Bik, Bak and Puma) and 
pro-survival Bcl-2 family proteins (Bcl-2, Bcl-xL and 
Mcl-1) in Bel-7402-(MRC-5)-CM and MHCC-LM3-
(MRC-5)-CM. The results indicated that typical cell 
cycle-related proteins and cell apoptosis-related pro-
teins (such as those mentioned above) did not play a 
key role in the MRC-5-CM model, and another novel 
mechanism mediating cancer cell proliferation and 
apoptosis must be present.
Conclusion
MRC-5-CM mediated multiple pathways regulating both 
proliferation and apoptosis in HCC cells. MRC-5-CM 
facilitated HCC cell invasion and migration through three 
mechanisms: redistribution of α-, β- and γ-catenin, P120 
catenin, E-cadherin and N-cadherin, activation of the integ-
rin/FAK/Src signaling pathway and upregulation of MMP2. 
We are not certain that the decreases in E-cadherin/β-
catenin complexes, as well as α-catenin, γ-catenin and P120 
catenin at the cell surface were due to the increased integrin 
expression, but we do know that α9β1 integrin can form a 
tri-partite protein complex with β-catenin and E-cadherin. 
Thus, we are conducting further study to explore the role of 
α6, β3, β4 and β7 integrins in HCC.
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